Improved Survival Associated with Neoadjuvant Chemoradiation in Patients with Clinical Stage IIIA (N2) Non-Small-Cell Lung Cancer Response

被引：0
|
作者：
Koshy, Matthew [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷 / 11期
关键词：
D O I：
10.1097/01.JTO.0000435804.68538.8c
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E101 / E101
页数：1
相关论文
共 50 条
  • [1] Improved Survival Associated with Neoadjuvant Chemoradiation in Patients with Clinical Stage IIIA (N2) Non-Small-Cell Lung Cancer
    Poullis, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (11) : E100 - E100
  • [2] Improved Survival Associated with Neoadjuvant Chemoradiation in Patients with Clinical Stage IIIA(N2) Non-Small-Cell Lung Cancer
    Koshy, Matthew
    Fedewa, Stacey A.
    Malik, Renu
    Ferguson, Mark K.
    Vigneswaran, Wickii T.
    Feldman, Lawrence
    Howard, Andrew
    Abdelhady, Khaled
    Weichselbaum, Ralph R.
    Virgo, Katherine S.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : 915 - 922
  • [3] Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer
    Darling, Gail E.
    Li, Fei
    Patsios, Demetris
    Massey, Christine
    Wallis, Adam G.
    Coate, Linda
    Keshavjee, Shaf
    Pierre, Andrew
    De Perrot, Marc
    Yasufuku, Kazuhiro
    Cypel, Marcelo
    Waddell, Tom
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2015, 48 (05) : 684 - 690
  • [4] Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
    Pless, Miklos
    Stupp, Roger
    Ris, Hans-Beat
    Stahel, Rolf A.
    Weder, Walter
    Thierstein, Sandra
    Gerard, Marie-Aline
    Xyrafas, Alexandros
    Frueh, Martin
    Cathomas, Richard
    Zippelius, Alfred
    Roth, Arnaud
    Bijelovic, Milorad
    Ochsenbein, Adrian
    Meier, Urs R.
    Mamot, Christoph
    Rauch, Daniel
    Gautschi, Oliver
    Betticher, Daniel C.
    Mirimanoff, Rene-Olivier
    Peters, Solange
    LANCET, 2015, 386 (9998): : 1049 - 1056
  • [5] Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non-Small-Cell Lung Cancer
    Berry, Mark F.
    Worni, Mathias
    Pietrobon, Ricardo
    D'Amico, Thomas A.
    Akushevich, Igor
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (06) : 744 - 752
  • [6] Survival of Patients with Unsuspected N2 (Stage IIIA) Non-Small Cell Lung Cancer
    Yamamichi, Takashi
    Harada, Masahiko
    Hishima, Tsunekazu
    Asakawa, Ayaka
    Okui, Masayuki
    Horio, Hirotoshi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S768 - S768
  • [7] SURVIVAL OF PATIENTS WITH UNSUSPECTED N2 (STAGE IIIA) NON-SMALL CELL LUNG CANCER
    Park, Chang Kwon
    Lee, Deok Heon
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S883 - S883
  • [8] Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer
    Kappers, Ingrid
    Klomp, Houke M.
    Burgers, Jacobus A.
    Van Zandwijk, Nico
    Haas, Rick L. M.
    van Pel, Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (25) : 4205 - 4207
  • [9] Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy
    Qu, Chenghao
    Li, Rongyang
    Han, Jingyi
    Yue, Weiming
    Tian, Hui
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [10] Management of stage IIIA (N2) non-small-cell lung cancer: a transatlantic perspectiveaEuro
    Rocco, Gaetano
    Nason, Katie
    Brunelli, Alex
    Varela, Gonzalo
    Waddell, Thomas
    Jones, David R.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (04) : 1025 - 1027
12345